On admission, three and six months after discharge, Chen et al. examined insulin sensitivity and fasting insulin secretion in COVID-19 patients without diabetes, and presented the first evidence that COVID-19 may increase the risk of insulin resistance in people without diabetes [25,30]. The gene discussed is INS; the disease is Insulin resistance.